What Role Should Genomic Classifier Testing Play in Prostate Cancer?
MedPage Today) — Genomic classifier (GC) tests do not appear to consistently influence risk classification or treatment decisions for patients with newly diagnosed prostate cancer considering first-line treatment, according to results from a…
Read More
